Loading…

Triglyceride–glucose index (TyG index) is a predictor of incident colorectal cancer: a population-based longitudinal study

Background Colorectal cancer (CRC), which is related with insulin resistance, is a one of the most common cancers. Triglyceride-glucose index (TyG index) was made for a marker of insulin resistance. We conducted the investigation of association between TyG index and incident CRC. Methods We examined...

Full description

Saved in:
Bibliographic Details
Published in:BMC endocrine disorders 2020-07, Vol.20 (1), p.1-113, Article 113
Main Authors: Okamura, Takuro, Hashimoto, Yoshitaka, Hamaguchi, Masahide, Obora, Akihiro, Kojima, Takao, Fukui, Michiaki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c540t-a09dd723bdb56f1027b56a274c4b8a9653bebfeba8453321c69f63dfde42c2f83
cites cdi_FETCH-LOGICAL-c540t-a09dd723bdb56f1027b56a274c4b8a9653bebfeba8453321c69f63dfde42c2f83
container_end_page 113
container_issue 1
container_start_page 1
container_title BMC endocrine disorders
container_volume 20
creator Okamura, Takuro
Hashimoto, Yoshitaka
Hamaguchi, Masahide
Obora, Akihiro
Kojima, Takao
Fukui, Michiaki
description Background Colorectal cancer (CRC), which is related with insulin resistance, is a one of the most common cancers. Triglyceride-glucose index (TyG index) was made for a marker of insulin resistance. We conducted the investigation of association between TyG index and incident CRC. Methods We examined the affect of TyG index on incident CRC in this historical cohort study of 27,944 (16,454 men and 11,490 women) participants. TyG index was calculated as ln [fasting triglycerides (mg/dL) × fasting plasma glucose (mg/dL)/2]. The impact of TyG index on incident CRC was investigated using Cox proportional hazard models, adjusting for sex, age, body mass index, smoking status, alcohol consumption, exercise, systolic blood pressure and creatinine. The covariate-adjusted receiver operating characteristic (ROC) curve calculated the area under the curve (AUC) and cut-off value of TyG index for the incidence of CRC. Results During the median 4.4-year follow-up, 116 participants were diagnosed as CRC. The cumulative incidence rate of CRC were 0.4%. In Cox proportional hazard model, the HRs of TyG index were 1.38 (95% Confidence interval (CI), 1.00–1.91, p = 0.049) after adjusting for covariates. In the covariate-adjusted ROC curve analysis, the cut-off value of TyG index for incident CRC was 8.272 (AUC 0.687 (95%CI, 0.637–737, sensitivity = 0.620, specificity = 0.668, p 
doi_str_mv 10.1186/s12902-020-00581-w
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_12532de08a6b40e1ac638d2c1fbc69c4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A631902472</galeid><doaj_id>oai_doaj_org_article_12532de08a6b40e1ac638d2c1fbc69c4</doaj_id><sourcerecordid>A631902472</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-a09dd723bdb56f1027b56a274c4b8a9653bebfeba8453321c69f63dfde42c2f83</originalsourceid><addsrcrecordid>eNptks9u1DAQxiMEoqXwApwicSmHFHucOA4HpKoqpVIlLsvZcvwneOWNFzuhrMSh78Ab8iTMNhWwCPng0cw3P-uzvqJ4SckZpYK_yRQ6AhUBUhHSCFrdPiqOad1CxQWwx3_VR8WznNeE0FYAeVocMWhJBw0_Lr6vkh_CTtvkjf1592MIs47Zln409lt5utpdLeXr0udSldtkjddTTGV0ONC4NE6ljiEmqycVSq1GZL3dS-N2Dmrycax6la0pQxwHP83Gj6jLWOyeF0-cCtm-eLhPik_vL1cXH6qbj1fXF-c3lW5qMlWKdMa0wHrTN9xRAi3eCtpa171QHW9Yb3tneyXqhjGgmneOM-OMrUGDE-ykuF64Jqq13Ca_UWkno_LyvhHTIFWavA5WUmgYGEuE4n1NLFWaM2FAU9cjVtfIerewtnO_sUaj_6TCAfRwMvrPcohfZcvaTjCKgNMHQIpfZpsnufFZ2xDUaOOcJdTQQica3qH01T_SdZwTft9exRpggN7_qAaFBvzoIr6r91B5zhnFiGAMUHX2HxUeYzdex9E6j_2DBVgWdIo5J-t-e6RE7vMnl_xJzJ-8z5-8Zb8AOv3OVA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2435232653</pqid></control><display><type>article</type><title>Triglyceride–glucose index (TyG index) is a predictor of incident colorectal cancer: a population-based longitudinal study</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Okamura, Takuro ; Hashimoto, Yoshitaka ; Hamaguchi, Masahide ; Obora, Akihiro ; Kojima, Takao ; Fukui, Michiaki</creator><creatorcontrib>Okamura, Takuro ; Hashimoto, Yoshitaka ; Hamaguchi, Masahide ; Obora, Akihiro ; Kojima, Takao ; Fukui, Michiaki</creatorcontrib><description>Background Colorectal cancer (CRC), which is related with insulin resistance, is a one of the most common cancers. Triglyceride-glucose index (TyG index) was made for a marker of insulin resistance. We conducted the investigation of association between TyG index and incident CRC. Methods We examined the affect of TyG index on incident CRC in this historical cohort study of 27,944 (16,454 men and 11,490 women) participants. TyG index was calculated as ln [fasting triglycerides (mg/dL) × fasting plasma glucose (mg/dL)/2]. The impact of TyG index on incident CRC was investigated using Cox proportional hazard models, adjusting for sex, age, body mass index, smoking status, alcohol consumption, exercise, systolic blood pressure and creatinine. The covariate-adjusted receiver operating characteristic (ROC) curve calculated the area under the curve (AUC) and cut-off value of TyG index for the incidence of CRC. Results During the median 4.4-year follow-up, 116 participants were diagnosed as CRC. The cumulative incidence rate of CRC were 0.4%. In Cox proportional hazard model, the HRs of TyG index were 1.38 (95% Confidence interval (CI), 1.00–1.91, p = 0.049) after adjusting for covariates. In the covariate-adjusted ROC curve analysis, the cut-off value of TyG index for incident CRC was 8.272 (AUC 0.687 (95%CI, 0.637–737, sensitivity = 0.620, specificity = 0.668, p &lt; 0.001)). Conclusions TyG index can predict the onset of CRC. For early detection of CRC, we should encourage people with high TyG index to undergo screening for CRC.</description><identifier>ISSN: 1472-6823</identifier><identifier>EISSN: 1472-6823</identifier><identifier>DOI: 10.1186/s12902-020-00581-w</identifier><identifier>PMID: 32709256</identifier><language>eng</language><publisher>London: BioMed Central Ltd</publisher><subject>Alcohol ; Blood pressure ; Blood tests ; Body mass index ; Cancer ; Cardiovascular disease ; Cell adhesion &amp; migration ; Cholesterol ; Cohort analysis ; Cohort study ; Colorectal cancer ; Colorectal carcinoma ; Creatinine ; Dextrose ; Diabetes ; Diagnosis ; Epidemiology ; Fasting ; Gene expression ; Glucose ; Hospitals ; Insulin ; Insulin resistance ; Insulin-like growth factors ; Laboratory testing ; Longitudinal studies ; Metabolism ; Oncology, Experimental ; Pathogenesis ; Plasma ; Population studies ; Population-based studies ; Questionnaires ; Risk factors ; Studies ; Triglycerides ; TyG index ; Type 2 diabetes ; Variance analysis</subject><ispartof>BMC endocrine disorders, 2020-07, Vol.20 (1), p.1-113, Article 113</ispartof><rights>COPYRIGHT 2020 BioMed Central Ltd.</rights><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-a09dd723bdb56f1027b56a274c4b8a9653bebfeba8453321c69f63dfde42c2f83</citedby><cites>FETCH-LOGICAL-c540t-a09dd723bdb56f1027b56a274c4b8a9653bebfeba8453321c69f63dfde42c2f83</cites><orcidid>0000-0002-8651-4445</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379831/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2435232653?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids></links><search><creatorcontrib>Okamura, Takuro</creatorcontrib><creatorcontrib>Hashimoto, Yoshitaka</creatorcontrib><creatorcontrib>Hamaguchi, Masahide</creatorcontrib><creatorcontrib>Obora, Akihiro</creatorcontrib><creatorcontrib>Kojima, Takao</creatorcontrib><creatorcontrib>Fukui, Michiaki</creatorcontrib><title>Triglyceride–glucose index (TyG index) is a predictor of incident colorectal cancer: a population-based longitudinal study</title><title>BMC endocrine disorders</title><description>Background Colorectal cancer (CRC), which is related with insulin resistance, is a one of the most common cancers. Triglyceride-glucose index (TyG index) was made for a marker of insulin resistance. We conducted the investigation of association between TyG index and incident CRC. Methods We examined the affect of TyG index on incident CRC in this historical cohort study of 27,944 (16,454 men and 11,490 women) participants. TyG index was calculated as ln [fasting triglycerides (mg/dL) × fasting plasma glucose (mg/dL)/2]. The impact of TyG index on incident CRC was investigated using Cox proportional hazard models, adjusting for sex, age, body mass index, smoking status, alcohol consumption, exercise, systolic blood pressure and creatinine. The covariate-adjusted receiver operating characteristic (ROC) curve calculated the area under the curve (AUC) and cut-off value of TyG index for the incidence of CRC. Results During the median 4.4-year follow-up, 116 participants were diagnosed as CRC. The cumulative incidence rate of CRC were 0.4%. In Cox proportional hazard model, the HRs of TyG index were 1.38 (95% Confidence interval (CI), 1.00–1.91, p = 0.049) after adjusting for covariates. In the covariate-adjusted ROC curve analysis, the cut-off value of TyG index for incident CRC was 8.272 (AUC 0.687 (95%CI, 0.637–737, sensitivity = 0.620, specificity = 0.668, p &lt; 0.001)). Conclusions TyG index can predict the onset of CRC. For early detection of CRC, we should encourage people with high TyG index to undergo screening for CRC.</description><subject>Alcohol</subject><subject>Blood pressure</subject><subject>Blood tests</subject><subject>Body mass index</subject><subject>Cancer</subject><subject>Cardiovascular disease</subject><subject>Cell adhesion &amp; migration</subject><subject>Cholesterol</subject><subject>Cohort analysis</subject><subject>Cohort study</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Creatinine</subject><subject>Dextrose</subject><subject>Diabetes</subject><subject>Diagnosis</subject><subject>Epidemiology</subject><subject>Fasting</subject><subject>Gene expression</subject><subject>Glucose</subject><subject>Hospitals</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>Insulin-like growth factors</subject><subject>Laboratory testing</subject><subject>Longitudinal studies</subject><subject>Metabolism</subject><subject>Oncology, Experimental</subject><subject>Pathogenesis</subject><subject>Plasma</subject><subject>Population studies</subject><subject>Population-based studies</subject><subject>Questionnaires</subject><subject>Risk factors</subject><subject>Studies</subject><subject>Triglycerides</subject><subject>TyG index</subject><subject>Type 2 diabetes</subject><subject>Variance analysis</subject><issn>1472-6823</issn><issn>1472-6823</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptks9u1DAQxiMEoqXwApwicSmHFHucOA4HpKoqpVIlLsvZcvwneOWNFzuhrMSh78Ab8iTMNhWwCPng0cw3P-uzvqJ4SckZpYK_yRQ6AhUBUhHSCFrdPiqOad1CxQWwx3_VR8WznNeE0FYAeVocMWhJBw0_Lr6vkh_CTtvkjf1592MIs47Zln409lt5utpdLeXr0udSldtkjddTTGV0ONC4NE6ljiEmqycVSq1GZL3dS-N2Dmrycax6la0pQxwHP83Gj6jLWOyeF0-cCtm-eLhPik_vL1cXH6qbj1fXF-c3lW5qMlWKdMa0wHrTN9xRAi3eCtpa171QHW9Yb3tneyXqhjGgmneOM-OMrUGDE-ykuF64Jqq13Ca_UWkno_LyvhHTIFWavA5WUmgYGEuE4n1NLFWaM2FAU9cjVtfIerewtnO_sUaj_6TCAfRwMvrPcohfZcvaTjCKgNMHQIpfZpsnufFZ2xDUaOOcJdTQQica3qH01T_SdZwTft9exRpggN7_qAaFBvzoIr6r91B5zhnFiGAMUHX2HxUeYzdex9E6j_2DBVgWdIo5J-t-e6RE7vMnl_xJzJ-8z5-8Zb8AOv3OVA</recordid><startdate>20200724</startdate><enddate>20200724</enddate><creator>Okamura, Takuro</creator><creator>Hashimoto, Yoshitaka</creator><creator>Hamaguchi, Masahide</creator><creator>Obora, Akihiro</creator><creator>Kojima, Takao</creator><creator>Fukui, Michiaki</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8651-4445</orcidid></search><sort><creationdate>20200724</creationdate><title>Triglyceride–glucose index (TyG index) is a predictor of incident colorectal cancer: a population-based longitudinal study</title><author>Okamura, Takuro ; Hashimoto, Yoshitaka ; Hamaguchi, Masahide ; Obora, Akihiro ; Kojima, Takao ; Fukui, Michiaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-a09dd723bdb56f1027b56a274c4b8a9653bebfeba8453321c69f63dfde42c2f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Alcohol</topic><topic>Blood pressure</topic><topic>Blood tests</topic><topic>Body mass index</topic><topic>Cancer</topic><topic>Cardiovascular disease</topic><topic>Cell adhesion &amp; migration</topic><topic>Cholesterol</topic><topic>Cohort analysis</topic><topic>Cohort study</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Creatinine</topic><topic>Dextrose</topic><topic>Diabetes</topic><topic>Diagnosis</topic><topic>Epidemiology</topic><topic>Fasting</topic><topic>Gene expression</topic><topic>Glucose</topic><topic>Hospitals</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>Insulin-like growth factors</topic><topic>Laboratory testing</topic><topic>Longitudinal studies</topic><topic>Metabolism</topic><topic>Oncology, Experimental</topic><topic>Pathogenesis</topic><topic>Plasma</topic><topic>Population studies</topic><topic>Population-based studies</topic><topic>Questionnaires</topic><topic>Risk factors</topic><topic>Studies</topic><topic>Triglycerides</topic><topic>TyG index</topic><topic>Type 2 diabetes</topic><topic>Variance analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Okamura, Takuro</creatorcontrib><creatorcontrib>Hashimoto, Yoshitaka</creatorcontrib><creatorcontrib>Hamaguchi, Masahide</creatorcontrib><creatorcontrib>Obora, Akihiro</creatorcontrib><creatorcontrib>Kojima, Takao</creatorcontrib><creatorcontrib>Fukui, Michiaki</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>BMC endocrine disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Okamura, Takuro</au><au>Hashimoto, Yoshitaka</au><au>Hamaguchi, Masahide</au><au>Obora, Akihiro</au><au>Kojima, Takao</au><au>Fukui, Michiaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Triglyceride–glucose index (TyG index) is a predictor of incident colorectal cancer: a population-based longitudinal study</atitle><jtitle>BMC endocrine disorders</jtitle><date>2020-07-24</date><risdate>2020</risdate><volume>20</volume><issue>1</issue><spage>1</spage><epage>113</epage><pages>1-113</pages><artnum>113</artnum><issn>1472-6823</issn><eissn>1472-6823</eissn><abstract>Background Colorectal cancer (CRC), which is related with insulin resistance, is a one of the most common cancers. Triglyceride-glucose index (TyG index) was made for a marker of insulin resistance. We conducted the investigation of association between TyG index and incident CRC. Methods We examined the affect of TyG index on incident CRC in this historical cohort study of 27,944 (16,454 men and 11,490 women) participants. TyG index was calculated as ln [fasting triglycerides (mg/dL) × fasting plasma glucose (mg/dL)/2]. The impact of TyG index on incident CRC was investigated using Cox proportional hazard models, adjusting for sex, age, body mass index, smoking status, alcohol consumption, exercise, systolic blood pressure and creatinine. The covariate-adjusted receiver operating characteristic (ROC) curve calculated the area under the curve (AUC) and cut-off value of TyG index for the incidence of CRC. Results During the median 4.4-year follow-up, 116 participants were diagnosed as CRC. The cumulative incidence rate of CRC were 0.4%. In Cox proportional hazard model, the HRs of TyG index were 1.38 (95% Confidence interval (CI), 1.00–1.91, p = 0.049) after adjusting for covariates. In the covariate-adjusted ROC curve analysis, the cut-off value of TyG index for incident CRC was 8.272 (AUC 0.687 (95%CI, 0.637–737, sensitivity = 0.620, specificity = 0.668, p &lt; 0.001)). Conclusions TyG index can predict the onset of CRC. For early detection of CRC, we should encourage people with high TyG index to undergo screening for CRC.</abstract><cop>London</cop><pub>BioMed Central Ltd</pub><pmid>32709256</pmid><doi>10.1186/s12902-020-00581-w</doi><orcidid>https://orcid.org/0000-0002-8651-4445</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1472-6823
ispartof BMC endocrine disorders, 2020-07, Vol.20 (1), p.1-113, Article 113
issn 1472-6823
1472-6823
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_12532de08a6b40e1ac638d2c1fbc69c4
source Publicly Available Content Database; PubMed Central
subjects Alcohol
Blood pressure
Blood tests
Body mass index
Cancer
Cardiovascular disease
Cell adhesion & migration
Cholesterol
Cohort analysis
Cohort study
Colorectal cancer
Colorectal carcinoma
Creatinine
Dextrose
Diabetes
Diagnosis
Epidemiology
Fasting
Gene expression
Glucose
Hospitals
Insulin
Insulin resistance
Insulin-like growth factors
Laboratory testing
Longitudinal studies
Metabolism
Oncology, Experimental
Pathogenesis
Plasma
Population studies
Population-based studies
Questionnaires
Risk factors
Studies
Triglycerides
TyG index
Type 2 diabetes
Variance analysis
title Triglyceride–glucose index (TyG index) is a predictor of incident colorectal cancer: a population-based longitudinal study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A39%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Triglyceride%E2%80%93glucose%20index%20(TyG%20index)%20is%20a%20predictor%20of%20incident%20colorectal%20cancer:%20a%20population-based%20longitudinal%20study&rft.jtitle=BMC%20endocrine%20disorders&rft.au=Okamura,%20Takuro&rft.date=2020-07-24&rft.volume=20&rft.issue=1&rft.spage=1&rft.epage=113&rft.pages=1-113&rft.artnum=113&rft.issn=1472-6823&rft.eissn=1472-6823&rft_id=info:doi/10.1186/s12902-020-00581-w&rft_dat=%3Cgale_doaj_%3EA631902472%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c540t-a09dd723bdb56f1027b56a274c4b8a9653bebfeba8453321c69f63dfde42c2f83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2435232653&rft_id=info:pmid/32709256&rft_galeid=A631902472&rfr_iscdi=true